A remarkable reduction in bowel and urinary side effects was reported when MRI was used instead of CT to guide stereotactic body radiotherapy for localized prostate cancer.
Medscape Medical News
A remarkable reduction in bowel and urinary side effects was reported when MRI was used instead of CT to guide stereotactic body radiotherapy for localized prostate cancer.
Medscape Medical News